Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073476
Status:
TERMINATED
Last Update Posted:
2006-06-22
First Post:
2003-11-21
Brief Title:
A Study to Evaluate the Efficacy and Safety of CP-101606 in Subjects With an Acute Stroke
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Double-Blind Placebo-Controlled Multi-Center Study to Evaluate the Efficacy and Safety of a 72-Hour Infusion of CP-101606 in Subjects With Acute Ischemic Stroke
Status:
TERMINATED
Status Verified Date:
2006-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether a new research medication is effective and safe for the treatment of acute stroke when given within 6 hours of the onset of stroke
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None